Apixaban Intermediate CAS 503615-03-0 3-Morpholino-1- (4-Nitrophenyl) -5,6-Dihydropyridin-2(1H) -hal daahir ≥99.0% (HPLC)

Sharaxaad Gaaban:

3-Morpholino-1-(4-Nitrophenyl)-5,6-Dihydropyridin-2(1H) -hal

CAS: 503615-03-0

Daahirsanaanta: ≥99.0% (HPLC)

Muuqashada: Budada jaalaha ah

Dhexe ee Apixaban (CAS: 503612-47-3)

Xiriirka: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Faahfaahinta Alaabta

Alaabooyinka La Xiriira

Tags Product

Sharaxaad:

Ruifu Chemical waa soo saaraha ugu horreeya ee 3-Morpholino-1- (4-Nitrophenyl) -5,6-Dihydropyridin-2 (1H) -hal (CAS: 503615-03-0) oo leh tayo sare.Kiimikada Ruifu waxay bixin kartaa gaarsiinta adduunka oo dhan, qiimo tartan ah, adeeg aad u wanaagsan, tiro yar iyo tiro badan oo la heli karo.Iibso Apixaban dhexdhexaadiyeyaasha,Please contact: alvin@ruifuchem.com

Dhexdhexaadiyayaasha Apixaban:

Guryaha Kiimikada:

Magaca Kiimikada 3-Morpholino-1-(4-Nitrophenyl)-5,6-Dihydropyridin-2(1H) -hal
La mid ah 3- (4-Morpholinyl) -1- (4-Nitrophenyl) -5,6-Dihydro-2 (1H) -Pyridinone;5,6-Dihydro-3- (4-Morpholinyl) -1- (4-Nitrophenyl) -2 (1H) - Pyridinone;Apixaban Intermediate 3;Apixaban Impurity 36;Habka Apixaban wasakhda 1
Heerka Saamiyada Suuqa dhexdiisa, Wax-soo-saarka Ganacsiga
Lambarka CAS 503615-03-0
Qaanuunka molecular C15H17N3O4
Miisaanka Molecular 303.31 g/mol
Meesha dhalaalaysa 165.0 ~ 170.0 ℃
Barta Karsan 506.5 ± 50.0 ℃
Cufnaanta 1.357g/ml
COA & MSDS La heli karo
Asal ahaan Shanghai, Shiinaha
Qaybta Dhexe ee Apixaban (CAS: 503612-47-3)
Summada Kiimikada Ruifu

Tilmaamaha:

Walxaha Heerarka Kormeerka Natiijooyinka
Muuqashada Budada jaalaha ah Budada jaalaha ah
Meesha dhalaalaysa 165.0 ~ 170.0 ℃ 167.0 ~ 170.0 ℃
Khasaare xagga qalajinta ≤0.50% 0.3%
Xumaanta Shakhsi ahaaneed (Max.) ≤0.50% 0.3%
Wadarta wasakhda ≤1.00% 0.6%
Daahirnimada / Habka Falanqaynta ≥99.0% (HPLC) 99.4%
1 H NMR Spectrum Waafaqsan Qaab-dhismeedka U hogaansama
LC/MS Waafaqsan Qaab-dhismeedka U hogaansama
Gabagabo Alaabta waa la tijaabiyay oo waafaqay tilmaamihii la bixiyay

Xidhmada/Kaydinta/Raridda:

Xidhmada:Dhalo, bacda bireed ee aluminium, 25kg/Drum kartoonada, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Weelka si adag u xidh oo ku kaydi qabow, qalalan (2 ~ 8 ℃) iyo bakhaar hawo wanaagsan leh oo ka fog walxaha aan ku habboonayn.Ka ilaali iftiinka iyo qoyaanka.
Rarida:Ku gaarsii adduunka oo dhan hawo, by FedEx/DHL Express.Bixi keenid degdeg ah oo la isku halayn karo.

503615-03-0 - Jidka synthetic:

www.ruifuchemical.com

Faa'iidooyinka

Awood ku filan: Tas-hiilaad ku filan iyo farsamoyaqaanno

Adeegga Xirfadlaha: Adeegga iibsashada hal joogsi

Xidhmada OEM: Xidhmada gaarka ah iyo summada ayaa diyaar ah

Gaadhida Degdega ah: Haddii kaydku ku jiro, dammaanad bixinta saddex maalmood ah

Supply xasiloon: Hayso kayd macquul ah

Taageerada Farsamada: Xalka tignoolajiyada waa la heli karaa

Adeegga Isku-dhafka Gaarka ah: Wuxuu u dhexeeyaa garaam ilaa kiilo

Tayo Sare: Waxaa la sameeyay nidaam hubinta tayada dhamaystiran

FAQ:

Sidee loo Iibsadaa?Fadlan la xidhiidhDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

Khibrad 15 Sano ah?Waxaan leenahay in ka badan 15 sano oo waayo-aragnimo ah oo ku saabsan soo saarista iyo dhoofinta ee tiro balaadhan oo ah dhexdhexaad ah daawooyinka tayada sare leh ama kiimikooyinka ganaax.

Suuqyada Waaweyn?Iibiya suuqa gudaha, Waqooyiga Ameerika, Yurub, Hindiya, Kuuriya, Jabbaan, Australia, iwm.

Faa'iidooyinka?Tayada sare, qiimo jaban, adeegyo xirfadeed iyo taageero farsamo, gaarsiin degdeg ah.

TayadaHubinta?Nidaamka xakamaynta tayada adag.Qalabka xirfadlayaasha ah ee falanqaynta waxaa ka mid ah NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Imtixaanka xadka Microbial, iwm.

Tusaalooyinka?Badeecadaha intooda badani waxay bixiyaan muunado bilaash ah oo loogu talagalay qiimeynta tayada, kharashka dhoofinta waa in ay bixiyaan macaamiisha.

Hantidhawrka Warshada?Hantidhawrka warshada soo dhawoow.Fadlan horay u sii ballan.

MOQ?Ma jiro MOQ.Dalabka yar waa la aqbali karaa.

Waqtiga dirida? Haddii ay ku jirto kaydka, dammaanad bixinta saddex maalmood ah.

Gaadiidka?By Express (FedEx, DHL), hawada, badda.

Dukumentiyada?Adeegga iibka kadib: COA, MOA, ROS, MSDS, iwm waa la bixin karaa.

Isku-dhafka gaarka ah?Waxay ku siin kartaa adeegyada isku-dhafka gaarka ah si ay ugu habboonaato baahiyahaaga cilmi-baarista.

Shuruudaha Lacag-bixinta?Qaansheegga Proforma ayaa marka hore la soo diri doonaa ka dib marka la xaqiijiyo dalabka, oo lagu soo lifaaqay macluumaadka bangigayaga.Lacag bixinta T/T (Telex Transfer), PayPal, Western Union, iwm.

Codsiga:

3-Morpholino-1- (4-Nitrophenyl) -5,6-Dihydropyridin-2 (1H) -hal (CAS: 503615-03-0) waa dhexdhexaadinta isku dhafka Apixaban (CAS: 503612-47-3) .
Apixaban waa nooc cusub oo ah Xa-xakameeyaha afka laga qaato oo ay si wadajir ah u soo saareen Bristol-Myers Squibb iyo Pfizer.Magaca ganacsiga waa Eratol, oo ah nooc cusub oo ah daawada xinjirowga lidka ku ah afka.Iyadoo la xakameynayo xinjirowga muhiimka ah ee Xa, Apixaban waxay ka hortagi kartaa soosaarka thrombin iyo xinjirowga dhiigga.
Bishii Abriil 26, 2007, Bristol-Myers Squibb waxay ku biirtay gacmaha Pfizer si ay ugu dhawaaqdo iskaashiga horumarinta daawada xinjirowga lidka ku ah afka ee cusub ee Apixaban oo ay leedahay Bristol-Myers Squibb oo ah beddelka warfarin oo la cusboonaysiiyay.Sida ku cad heshiiska iskaashiga, Pfizer waxay bixin doontaa lacag horudhac ah oo US $ 0.25 bilyan ah Bristol-Myers Squibb si ay u qaadato 60% wadarta kharashka horumarinta daawada xinjirowga lidka ku ah ee Apixaban (laga bilaabo Janaayo 1, 2007), halka Bristol-Myers Squibb wuxuu qaadi doonaa inta soo hartay 40%, si uu u helo xuquuqda wadajirka ah ee horumarinta iyo iibinta daawada.
Bishii Maajo 2011, Apixaban wuxuu ahaa kii ugu horreeyay ee oggolaaday ka hortagga xinjirowga dhiigga ee bukaannada qaangaarka ah ee ku socda qalliinka beddelka miskaha ama jilibka ee la doortay ee 27 dalalka EU, Iceland iyo Norway.
Noofambar 20, 2012, Komishanka Yurub ayaa ansixiyay Ererto (Apixaban) si looga hortago istaroogga iyo embolism-ka habdhiska bukaanka ee bukaannada qaangaarka ah ee qaba fibrillation aan valvular ahayn (NVAF) oo leh hal ama dhowr arrimood oo halis ah.Ka dib, Maamulka Cuntada iyo Dawooyinka ee Kanadiyaanka, Japan, iyo US FDA waxay ansixiyeen Ererto (Apixaban) ka hortagga istaroogga iyo embolism-ka nidaamka ee bukaannada qaangaarka ah ee qaba fibrillation aan valvular ahayn (NVAF) oo leh hal ama dhowr arrimood oo halis ah.
Abriil 12, 2013, dawada cusub ee xinjirowga lidka ku ah ee Eloto (ELIQUIS)(apixaban) oo ay si wadajir ah u sameeyeen Bristol-Myers Squibb iyo Pfizer ayaa si rasmi ah loogu dhawaaqay in lagu taxay Shiinaha.Ererto waa cunsur cusub oo afka laga qaato Xa inhibitor oo loogu talagalay ka hortagga xinjirowga dhiigga xididada (VTE) ee bukaannada qaangaarka ah ee lagu beddelayo sinta ama jilibka ee la doortay.Liiskeedu wuxuu bixiyaa doorasho cusub oo badbaado leh oo waxtar leh oo loogu talagalay xinjirowga lidka ku ah bukaan-socodka ka dib qalliinka lafaha, waxayna u keentaa war wanaagsan bukaannada Shiinaha ee maraya beddelka miskaha/jilibka.Daraasadaha caafimaadku waxay xaqiijiyeen in marka la barbar dhigo 40mg enoxaparin hal mar maalintii, 2 jeer maalintii maamulka afka ee Eratol (Apixaban) 2.5mg ayaa aad waxtar ugu leh ka hortagga xinjirowga xididdada xididdada dhiigga ka dib qalliinka beddelka sinta ama jilibka, mana kordhinayso khatarta dhiig-baxa.

Halkan ku qor fariintaada oo noo soo dir